Natural products in anti-tuberculosis host-directed therapy
Article in Biomedicine & Pharmacotherapy (January 2024)
The most recent citing publications are shown below. View all 67 publications that cite this research output on Dimensions.
Inhibition of host PARP1 contributes to the anti-inflammatory and antitubercular activity of pyrazinamide
Article in Nature Communications (December 2023)
Dominant negative biologics normalise the tumour necrosis factor (TNF-α) induced angiogenesis which exploits the Mycobacterium tuberculosis dissemination
Article in BMC Immunology (November 2023)